Out of these six, we chose the three cancer types with the highest statistical significance in tumor/normal tissue for miR-192-5p and ZEB2 differential expression (breast invasive carcinoma, BRCA; uterine corpus endometrial carcinoma, UCEC; and lung adenocarcinoma, LUAD) and analyzed the survival time of patients according to the miR-192-5p/ZEB2 expression patterns. This evidence concerns the gene ZEB2 and cancer.